Found 0 matching trials
A Study of the CDX-1307 Vaccine Regimen in Patients With Newly Diagnosed Muscle-Invasive Bladder Cancer (The "N-ABLE" Study) PHASE2 The major purpose of this study is to examine the anti-tumor activity of th...
Show More Learn More & Join Trial
R-EPOCH in Combination With Ibrutinib for Patients With Classical RT of CLL PHASE2 This is an investigator-initiated Phase 2 study, which combines R-EDOCH wit...
Show More Location
Peking university Third Hospital
Learn More & Join Trial
Exemption of SLNB After Neoadjuvant Therapy for Triple-negative and Her2-positive Breast Cancer NA The neoadjuvant system therapy (NAST) can significantly increase the pathol...
Show More Status
Active Not Recruiting
Learn More & Join Trial
A Study to Evaluate the Safety and Efficacy of Oral APL-1202 in Combination With Tislelizumab Compared to Tislelizumab Alone as Neoadjuvant Therapy in Patients With Muscle Invasive Bladder Cancer PHASE1 This trial is designed to evaluate the safety, efficacy, and biomarker resp...
Show More Location
Mount Sinai Medical Center
Learn More & Join Trial
Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib PHASE2 The purpose of this study is to better understand how the immune system pla...
Show More Location
Parkland Hospital
Learn More & Join Trial
Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial 3 PHASE3 This pivotal, confirmatory trial seeks to independently verify the results ...
Show More Location
Multiple Locations
Learn More & Join Trial
Conformal Radiotherapy (CRT) Alone Versus CRT Combined With HDR BT or Stereotactic Body Radiotherapy for Prostate Cancer PHASE3 The purpose of this study is to compare the outcomes of conventionally frac...
Show More Location
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch
Learn More & Join Trial
NUVOLA TRIAL Open-label Multicentre Study PHASE2 Around 15-25% of ovarian cancer (OC) patients carry germ-line mutation in B...
Show More Location
Fondazione Policlinico Gemelli IRCCS
Learn More & Join Trial
Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE) PHASE3 This randomized phase 3 trial is studying the effect of denosumab to see if...
Show More Learn More & Join Trial
Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer PHASE3 A randomized multi-arm study evaluating the efficacy and safety of nivoluma...
Show More Location
Local Institution - 0136
Learn More & Join Trial